Home
>
National Drug Code (NDC)
>
Atenolol
Atenolol - 13107-168-01 - (Atenolol)
Drug Information of Atenolol
| Product NDC: | 13107-168 |
| Proprietary Name: | Atenolol |
| Non Proprietary Name: | Atenolol |
| Active Ingredient(s): | 25 mg/1 & nbsp; Atenolol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Atenolol
| Product NDC: | 13107-168 |
| Labeler Name: | Aurolife Pharma LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078512 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110620 |
Package Information of Atenolol
| Package NDC: | 13107-168-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (13107-168-01) |
NDC Information of Atenolol
| NDC Code | 13107-168-01 |
| Proprietary Name | Atenolol |
| Package Description | 100 TABLET in 1 BOTTLE (13107-168-01) |
| Product NDC | 13107-168 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Atenolol |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110620 |
| Marketing Category Name | ANDA |
| Labeler Name | Aurolife Pharma LLC |
| Substance Name | ATENOLOL |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
